At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 17:00 ET
Director Christopher Patusky filed a Form 144 notice of intent to sell 1,210 shares of United Therapeutics Corp common stock, valued at approximately $701,800 based on the filing. The shares were acquired through a stock option exercise on the same date. This is a routine insider sale by a director, representing a small fraction of the company's $24.1B market cap.
- Director Christopher Patusky filed Form 144 to sell 1,210 shares of United Therapeutics Corp common stock.
- The approximate market value of the proposed sale is $701,800.
- Shares were acquired via a stock option exercise on November 9, 2026.
- The sale is planned for execution on November 9, 2026, through Morgan Stanley Smith Barney LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access